These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8044794)

  • 1. Hyperphosphorylation of p53 induced by okadaic acid attenuates its transcriptional activation function.
    Zhang W; McClain C; Gau JP; Guo XY; Deisseroth AB
    Cancer Res; 1994 Aug; 54(16):4448-53. PubMed ID: 8044794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactive p53 mutants may enhance the transcriptional activity of wild-type p53.
    Zhang W; Shay JW; Deisseroth A
    Cancer Res; 1993 Oct; 53(20):4772-5. PubMed ID: 8402659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperphosphorylation of retinoblastoma protein and p53 by okadaic acid, a tumor promoter.
    Yatsunami J; Komori A; Ohta T; Suganuma M; Fujiki H
    Cancer Res; 1993 Jan; 53(2):239-41. PubMed ID: 8417815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complex regulation of the DNA-binding activity of p53 by phosphorylation: differential effects of individual phosphorylation sites on the interaction with different binding motifs.
    Hecker D; Page G; Lohrum M; Weiland S; Scheidtmann KH
    Oncogene; 1996 Mar; 12(5):953-61. PubMed ID: 8649812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of synthesis and phosphorylation of nuclear protein factors that bind to the positive cis-acting element in the transcriptional activation of the CYP2B1/B2 gene by phenobarbitone in vivo.
    Nirodi CS; Sultana S; Ram N; Prabhu L; Padmanaban G
    Arch Biochem Biophys; 1996 Jul; 331(1):79-86. PubMed ID: 8660686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of serum response element in okadaic acid-induced EGR-1 transcription in human T-cells.
    Chauhan D; Kharbanda SM; Uchiyama H; Sukhatme VP; Kufe DW; Anderson KC
    Cancer Res; 1994 Apr; 54(8):2234-9. PubMed ID: 8174132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional regulation of the early growth response 1 gene in human myeloid leukemia cells by okadaic acid.
    Kharbanda S; Rubin E; Datta R; Hass R; Sukhatme V; Kufe D
    Cell Growth Differ; 1993 Jan; 4(1):17-23. PubMed ID: 8381016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation of p53 at serine 37 is important for transcriptional activity and regulation in response to DNA damage.
    Dohoney KM; Guillerm C; Whiteford C; Elbi C; Lambert PF; Hager GL; Brady JN
    Oncogene; 2004 Jan; 23(1):49-57. PubMed ID: 14712210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional induction of cyclooxygenase-2 gene by okadaic acid inhibition of phosphatase activity in human chondrocytes: co-stimulation of AP-1 and CRE nuclear binding proteins.
    Miller C; Zhang M; He Y; Zhao J; Pelletier JP; Martel-Pelletier J; Di Battista JA
    J Cell Biochem; 1998 Jun; 69(4):392-413. PubMed ID: 9620167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The requirement of the carboxyl terminus of p53 for DNA binding and transcriptional activation depends on the specific p53 binding DNA element.
    Zhang W; Guo XY; Deisseroth AB
    Oncogene; 1994 Sep; 9(9):2513-21. PubMed ID: 8058314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Okadaic acid inhibits dephosphorylation of cytoplasmic p53 during lymphocyte activation.
    McClure JE; Noonan CA; Shearer WT
    Biochem Biophys Res Commun; 1993 Dec; 197(3):1578-84. PubMed ID: 8280176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distance constraints and stereospecific alignment requirements characteristic of p53 DNA-binding consensus sequence homologies.
    Cook JL; Ré RN; Giardina JF; Fontenot FE; Cheng DY; Alam J
    Oncogene; 1995 Aug; 11(4):723-33. PubMed ID: 7651736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signaling to p53: breaking the posttranslational modification code.
    Appella E; Anderson CW
    Pathol Biol (Paris); 2000 Apr; 48(3):227-45. PubMed ID: 10858956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation studies on rat p53 using the baculovirus expression system. Manipulation of the phosphorylation state with okadaic acid and influence on DNA binding.
    Fuchs B; Hecker D; Scheidtmann KH
    Eur J Biochem; 1995 Mar; 228(3):625-39. PubMed ID: 7737156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The involvement of "tumor suppressor" p53 in normal and chronic myelogenous leukemia hemopoiesis.
    Bi S; Lanza F; Goldman JM
    Cancer Res; 1994 Jan; 54(2):582-6. PubMed ID: 8275497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Redox modulation of p53 conformation and sequence-specific DNA binding in vitro.
    Hainaut P; Milner J
    Cancer Res; 1993 Oct; 53(19):4469-73. PubMed ID: 8402615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of PP2A, but not PP5, mediates p53 activation by low levels of okadaic acid in rat liver epithelial cells.
    Messner DJ; Romeo C; Boynton A; Rossie S
    J Cell Biochem; 2006 Sep; 99(1):241-55. PubMed ID: 16598789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 derived from human tumour cell lines and containing distinct point mutations can be activated to bind its consensus target sequence.
    Niewolik D; Vojtesek B; Kovarik J
    Oncogene; 1995 Mar; 10(5):881-90. PubMed ID: 7898929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SV40 T antigen abrogates p53-mediated transcriptional activity.
    Jiang D; Srinivasan A; Lozano G; Robbins PD
    Oncogene; 1993 Oct; 8(10):2805-12. PubMed ID: 8378089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The DNA-binding and transcription-activation abilities of p53 are necessary but not sufficient for its antiproliferation function.
    Zhang W; Randhawa GS; Guo XY; Deisseroth AB
    Cell Growth Differ; 1994 Jul; 5(7):705-10. PubMed ID: 7947385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.